Compare Merck & Co., Inc. (MRK) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Tractor Supply Co — how do they compare? Merck & Co., Inc. trades at $133.55 (market cap $321.77B), while Tractor Supply Co trades at $36.38 (market cap $18.39B). The key difference: Merck & Co., Inc. is far larger — about 17.5× Tractor Supply Co's market cap, and Tractor Supply Co pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| MRK | TSCO | |
|---|---|---|
Market Cap | $321.77B | $18.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $131.84 | $62.65 |
52-Week Low | $77.60 | $29.14 |
Enterprise Value | $368.53B | $24.70B |
Dividend Yield | 2.61% | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck & Co. (MRK) trades at $133.64, up 2.09% today, with a bullish technical signal from moving averages and strong institutional buying interest. The company reported solid earnings beats in recent quarters, with Q3 2026 EPS expected at $2.27. Revenue for 2025 reached $65.01B, and net income was $18.25B, though the P/E ratio of 104.34 suggests high valuation expectations. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline.
Outlook: MRK's growth is supported by strategic acquisitions and a dominant oncology franchise, but risks include high valuation multiples and competitive pressures. The consensus price target of $140.36 implies modest upside, with 68% of analysts rating it a Buy. Investors should monitor execution on the Terns integration and Q3 earnings results for catalysts.
Tractor Supply (TSCO) trades at $36.24, up 4.68% today, with a mixed technical picture showing bullish moving averages but overbought RSI levels. Fundamentally, the company reported $15.52B in 2025 revenue with a net margin of 6.42%, though recent quarters saw EPS misses. Valuation metrics include a P/E of 18.38 and ROE of 39.51%, indicating strong profitability but high price-to-book at 6.99. Recent news highlights CEO share purchases and dividend declarations amid a 2026 outlook cut due to weak demand.
The stock presents a cautious opportunity with solid fundamentals offset by near-term headwinds. Upside potential exists from digital growth and pet initiatives, but risks include discretionary spending pressure and cost inflation. Analysts are divided, with a $36.29 price target suggesting limited upside from current levels, requiring careful monitoring of holiday sales and margin trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
